Patterns of lymph node metastasis in 441 patients with sinonasal squamous cell carcinoma.

IF 4.3 2区 医学 Q2 ONCOLOGY Therapeutic Advances in Medical Oncology Pub Date : 2024-11-16 eCollection Date: 2024-01-01 DOI:10.1177/17588359241299331
Li Wang, Jie Wang, Tian Wang, Yi Li, Xinmao Song
{"title":"Patterns of lymph node metastasis in 441 patients with sinonasal squamous cell carcinoma.","authors":"Li Wang, Jie Wang, Tian Wang, Yi Li, Xinmao Song","doi":"10.1177/17588359241299331","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Due to the rarity of sinonasal squamous cell carcinoma (SNSCC), the distribution patterns of lymph node metastasis (LNM), the relationship between LNM and prognosis, and the optimal treatment of LNM lack sufficient evidence-based support.</p><p><strong>Objectives: </strong>To investigate the patterns of LNM in SNSCC and evaluate the impact of LNM on prognosis.</p><p><strong>Design: </strong>This was a retrospective cohort study.</p><p><strong>Methods: </strong>The medical records of 441 patients with SNSCC between 2009 and 2022 in one institution were retrospectively reviewed. We assessed the incidence, the distribution of LNM, and the relationship between LNM and long-term survival.</p><p><strong>Results: </strong>Seventy-three out of 441 patients (16.6%) presented LNM initially. Among the 73 patients, 34 patients (46.6%) had LNM in the region of ipsilateral level II; 22 patients (30.1%) had positive retropharyngeal lymph nodes; 20 patients (27.4%) had LNM in the region of ipsilateral level Ib; and nine patients (12.3%) had evidence of parotid LNM. Poor differentiation (<i>p</i> = 0.001), nasal cavity (<i>p</i> = 0.018), skin involvement (<i>p</i> = 0.036), and nasopharynx involvement (<i>p</i> = 0.009) were the risk factors for LNM. In the univariate and multivariate analyses, the overall survival (<i>p</i> = 0.25), progression-free survival (<i>p</i> = 0.22), regional failure-free survival (<i>p</i> = 0.20), and distant metastasis-free survival (<i>p</i> = 0.14) rates were not significantly decreased by the LNM. After the propensity score matching, LNM was still not correlated with poor long-term survival.</p><p><strong>Conclusions: </strong>The incidence of retropharyngeal and parotid LNM was higher than in previous studies. At initial diagnosis, the risk factors for LNM were identified, and LNM was not associated with poor survival outcomes.</p>","PeriodicalId":23053,"journal":{"name":"Therapeutic Advances in Medical Oncology","volume":"16 ","pages":"17588359241299331"},"PeriodicalIF":4.3000,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569498/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Medical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17588359241299331","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Due to the rarity of sinonasal squamous cell carcinoma (SNSCC), the distribution patterns of lymph node metastasis (LNM), the relationship between LNM and prognosis, and the optimal treatment of LNM lack sufficient evidence-based support.

Objectives: To investigate the patterns of LNM in SNSCC and evaluate the impact of LNM on prognosis.

Design: This was a retrospective cohort study.

Methods: The medical records of 441 patients with SNSCC between 2009 and 2022 in one institution were retrospectively reviewed. We assessed the incidence, the distribution of LNM, and the relationship between LNM and long-term survival.

Results: Seventy-three out of 441 patients (16.6%) presented LNM initially. Among the 73 patients, 34 patients (46.6%) had LNM in the region of ipsilateral level II; 22 patients (30.1%) had positive retropharyngeal lymph nodes; 20 patients (27.4%) had LNM in the region of ipsilateral level Ib; and nine patients (12.3%) had evidence of parotid LNM. Poor differentiation (p = 0.001), nasal cavity (p = 0.018), skin involvement (p = 0.036), and nasopharynx involvement (p = 0.009) were the risk factors for LNM. In the univariate and multivariate analyses, the overall survival (p = 0.25), progression-free survival (p = 0.22), regional failure-free survival (p = 0.20), and distant metastasis-free survival (p = 0.14) rates were not significantly decreased by the LNM. After the propensity score matching, LNM was still not correlated with poor long-term survival.

Conclusions: The incidence of retropharyngeal and parotid LNM was higher than in previous studies. At initial diagnosis, the risk factors for LNM were identified, and LNM was not associated with poor survival outcomes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
441 名鼻窦鳞状细胞癌患者的淋巴结转移模式。
背景:由于鼻窦鼻腔鳞状细胞癌(SNSCC)的罕见性,淋巴结转移(LNM)的分布模式、LNM与预后的关系以及LNM的最佳治疗方法缺乏足够的证据支持:调查SNSCC淋巴结转移的模式,评估LNM对预后的影响:这是一项回顾性队列研究:方法:回顾性分析某机构2009年至2022年间441例SNSCC患者的病历。我们评估了LNM的发生率、分布以及LNM与长期生存之间的关系:441例患者中有73例(16.6%)最初出现LNM。在这 73 名患者中,34 名患者(46.6%)的 LNM 位于同侧 II 层区域;22 名患者(30.1%)的咽后淋巴结呈阳性;20 名患者(27.4%)的 LNM 位于同侧 Ib 层区域;9 名患者(12.3%)有腮腺 LNM 的证据。分化不良(p = 0.001)、鼻腔(p = 0.018)、皮肤受累(p = 0.036)和鼻咽部受累(p = 0.009)是导致 LNM 的危险因素。在单变量和多变量分析中,总生存率(p = 0.25)、无进展生存率(p = 0.22)、无区域衰竭生存率(p = 0.20)和无远处转移生存率(p = 0.14)均未因LNM而显著降低。经过倾向评分匹配后,LNM与长期生存率低仍无相关性:结论:咽后和腮腺LNM的发病率高于以往的研究。结论:与之前的研究相比,咽后和腮腺 LNM 的发病率较高,在初步诊断时,LNM 的风险因素已被识别,LNM 与不良的生存结果无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.20
自引率
2.00%
发文量
160
审稿时长
15 weeks
期刊介绍: Therapeutic Advances in Medical Oncology is an open access, peer-reviewed journal delivering the highest quality articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of cancer. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in medical oncology, providing a forum in print and online for publishing the highest quality articles in this area. This journal is a member of the Committee on Publication Ethics (COPE).
期刊最新文献
Perspective review: lessons from successful clinical trials and real-world studies of systemic therapy for metastatic pheochromocytomas and paragangliomas. Antibody-drug conjugates in patients with advanced/metastatic HER2-low-expressing breast cancer: a systematic review and meta-analysis. Epithelioid inflammatory myofibroblastic sarcoma with exceptionally long response to lorlatinib-a case report. Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study. Comprehensive geriatric assessment guided radiotherapy in elderly patients with locally advanced rectal cancer-exploratory results on nonoperative cohort of a multicenter prospective study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1